We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAR icon
351
Interparfums
IPAR
$3.99B
$3.64M 0.05%
27,731
-12,172
-31% -$1.49M
IVR icon
352
Invesco Mortgage Capital
IVR
$759M
$3.56M 0.05%
453,848
-42,449
-9% -$313K
TXN icon
353
Texas Instruments
TXN
$252B
$3.56M 0.05%
17,125
ARR
354
Armour Residential REIT
ARR
$2.33B
$3.49M 0.05%
207,780
+91,554
+79% +$1.47M
MTH icon
355
Meritage Homes
MTH
$4.58B
$3.49M 0.05%
52,053
-4,107
-7% -$272K
IMMR icon
356
Immersion
IMMR
$251M
$3.48M 0.05%
441,514
-40,478
-8% -$301K
WMB icon
357
Williams Companies
WMB
$87.5B
$3.46M 0.05%
55,114
BMI icon
358
Badger Meter
BMI
$3.89B
$3.41M 0.05%
13,904
+3,284
+31% +$744K
AMRX icon
359
Amneal Pharmaceuticals
AMRX
$5.85B
$3.4M 0.05%
420,293
-39,151
-9% -$295K
NHC icon
360
National Healthcare
NHC
$3.53B
$3.35M 0.05%
31,337
-2,434
-7% -$243K
DAN icon
361
Dana Inc
DAN
$2.9B
$3.33M 0.05%
194,338
+11,711
+6% +$175K
GBX icon
362
The Greenbrier Companies
GBX
$1.52B
$3.32M 0.05%
72,002
-5,784
-7% -$259K
NEE icon
363
NextEra Energy
NEE
$181B
$3.28M 0.05%
47,296
VLY icon
364
Valley National Bancorp
VLY
$7.9B
$3.25M 0.05%
+363,895
New +$3.16M
ARDT
365
Ardent Health
ARDT
$1.53B
$3.25M 0.05%
237,747
-22,002
-8% -$296K
TILE icon
366
Interface
TILE
$1.99B
$3.23M 0.05%
154,198
-12,136
-7% -$240K
BCC icon
367
Boise Cascade
BCC
$2.69B
$3.23M 0.05%
37,170
-3,306
-8% -$300K
NMRK icon
368
Newmark Group
NMRK
$2.66B
$3.22M 0.05%
264,834
-20,623
-7% -$231K
KBH icon
369
KB Home
KBH
$3.37B
$3.22M 0.05%
60,712
-4,611
-7% -$245K
NEWT icon
370
NewtekOne
NEWT
$428M
$3.21M 0.05%
284,754
+127,781
+81% +$1.37M
PLAB icon
371
Photronics
PLAB
$1.79B
$3.2M 0.04%
169,759
-15,958
-9% -$299K
OSPN icon
372
OneSpan
OSPN
$574M
$3.13M 0.04%
187,606
-16,809
-8% -$261K
BNL icon
373
Broadstone Net Lease
BNL
$4.11B
$3.09M 0.04%
192,251
+12,275
+7% +$197K
VO icon
374
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$3.01M 0.04%
43,056
-2,864
-6% -$188K
ET icon
375
Energy Transfer Partners
ET
$70.1B
$3M 0.04%
165,499

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.